Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of SIB-IMRT in Combination With 5-FU and Mitomycin-C Among Patients With Locally Advanced Anal Canal Cancer: Efficacy, Safety and Quality of Life

NCT02701088 is registered in ClinicalTrials.gov with Centre Francois Baclesse as lead sponsor.

NCT NCT02701088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02701088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of SIB-IMRT in Combination With 5-FU and Mitomycin-C Among Patients With Locally Advanced Anal Canal Cancer: Efficacy, Safety and Quality of Life
Lead sponsor
Centre Francois Baclesse
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2015
Completion date
December 31, 2025
Enrollment
71 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced anal canal cancer